News Archives

News Archives

Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2017

Ottawa, ON – December 20, 2017 — Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, today reported its audited financial results for the year ended October 31, 2017 and provided highlights of its fiscal …Read More

Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants

Ottawa, ON – December 8, 2017 — Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, is pleased to announce that it has received TSX Venture Exchange approval to extend the expiry date of outstanding …Read More

Avivagen Announces Closing of Private Placement Totaling $4 million

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE  UNITED STATES. Ottawa, ON — November 30, 2017 — Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products …Read More

Avivagen Announces the Appointment of Mr. Aubrey Dan to the Board of Directors

Ottawa, ON / TNW-Accesswire / November 22, 2017 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXF) (Avivagen or the Corporation), a life sciences innovation company with a series of patent protected products that support and optimize human and animal health, is delighted to welcome Mr. Aubrey Dan to the Board of Directors. Mr. Dan is a …Read More

Cesar Millan Helps Avivagen Relaunch Vivamune™ Health Chews in U.S.

Ottawa, ON / October 23, 2017 – Avivagen Inc. (Avivagen | TSXV: VIV, OTC Pink: CHEXF), a life sciences innovation company with a series of patent protected products that support and optimize animal health, is excited to announce the relaunch of its Vivamune™ Health Chew supplement (Vivamune) for dogs in the U.S. “My focus has …Read More

Avivagen Announces Chief Executive Officer and Issuance of Third Quarter Results

Ottawa, ON / TNW-Accesswire / September 7, 2017 / – Avivagen Inc. (TSXV:VIV, OTC Pink:CHEXF) (Avivagen or the Corporation), a corporation with a proven and commercially-ready, patent-protected product intended to replace the antibiotics added to livestock feeds as growth promoters, announces that, in view of the progress of the Corporation, the board of directors has …Read More